Radiofrequency ablation of the centromedian thalamic nucleus in the treatment of drug-resistant epilepsy.
Epilepsy Behav
; 114(Pt A): 107560, 2021 01.
Article
em En
| MEDLINE
| ID: mdl-33243680
ABSTRACT
OBJECTIVE:
To determine the usefulness and efficacy of radiofrequency ablations (RFA) of the Centromedian thalamic nucleus (CMN) to control primarily generalized or multifocal seizures in refractory epilepsy.METHODS:
Six patients with clinical diagnosis of multifocal or primarily generalized drug-resistant epilepsy were included. Bilateral RFA of the CMN was performed through a monopolar 1.8â¯mm. tip electrode with a temperature of 80⯰C during 90 seconds. Patients were followed in every 3â¯months visit for 20 to 36â¯months and kept a monthly seizure count calendar. We also compared maximal paroxysmal electroencephalogram (EEG) activity and neuropsychological evaluation pre and 6â¯months postoperatively.RESULTS:
A significant reduction in the number of generalized seizures was observed in all subjects in the range of 79-98%, starting the first post-operative month. Although focal aware seizures remained unchanged throughout follow-up, there was an important reduction on paroxysmal activity between the pre and postoperative EEG. No major changes on cognitive status were detected. There was post-operative dysphagia and odynophagia lasting one week and there was no mortality in this group of patients.CONCLUSION:
Preliminary results of CMN RFA suggest safety and a trend toward reduction of some seizure types, it may reduce the seizure frequency like other palliative procedures since the first post-operative month, but a larger, controlled study would be needed to establish the value of this therapy.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Preparações Farmacêuticas
/
Núcleos Intralaminares do Tálamo
/
Epilepsia Resistente a Medicamentos
/
Ablação por Radiofrequência
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article